Molecular imaging of cancer: MR spectroscopy and beyond.
暂无分享,去创建一个
T. Helbich | W. Bogner | A. Stadlbauer | S. Gruber | K. Pinker | T H Helbich | W Bogner | S Gruber | K Pinker | A Stadlbauer | Wolfgang Bogner | T. H. Helbich | Katja Pinker | Andreas Stadlbauer
[1] T. Helbich,et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? , 2009, Radiology.
[2] Wolfgang Bogner,et al. A Combined High Temporal and High Spatial Resolution 3 Tesla MR Imaging Protocol for the Assessment of Breast Lesions: Initial Results , 2009, Investigative radiology.
[3] Katarzyna J Macura,et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.
[4] P. Aspelin,et al. Diffusion-weighted magnetic resonance imaging of pancreas tumours , 2009, European Radiology.
[5] L. Turnbull. Dynamic contrast‐enhanced MRI in the diagnosis and management of breast cancer , 2009, NMR in biomedicine.
[6] Daniel B. Vigneron,et al. Advances in MR spectroscopy of the prostate. , 2008, Magnetic resonance imaging clinics of North America.
[7] C. Mountford,et al. Evaluation of Ovarian Tumors by Proton Magnetic Resonance Spectroscopy at Three Tesla , 2008, Investigative radiology.
[8] John V Frangioni,et al. New technologies for human cancer imaging. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Christopher Nimsky,et al. Metabolic Imaging of Cerebral Gliomas: Spatial Correlation of Changes in O-(2-18F-Fluoroethyl)-l-Tyrosine PET and Proton Magnetic Resonance Spectroscopic Imaging , 2008, Journal of Nuclear Medicine.
[10] M. Tozaki. Proton MR spectroscopy of the breast , 2008, Breast cancer.
[11] A. Fausto,et al. MR spectroscopy of the breast , 2008, La radiologia medica.
[12] H. Hricak,et al. Prostate cancer imaging , 2008, Acta radiologica.
[13] K. Togashi,et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas , 2007, European Radiology.
[14] R. Ouwerkerk. Sodium magnetic resonance imaging: from research to clinical use. , 2007, Journal of the American College of Radiology : JACR.
[15] Wei Huang,et al. Proton (1H) MR spectroscopy of the breast. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.
[16] Wei Huang,et al. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. , 2007, Radiology.
[17] C. Kuhl. Current status of breast MR imaging. Part 2. Clinical applications. , 2007, Radiology.
[18] K. Togashi,et al. Diffusion‐weighted MR imaging of uterine endometrial cancer , 2007, Journal of magnetic resonance imaging : JMRI.
[19] C. Kuhl. Breast MR imaging at 3T. , 2007, Magnetic resonance imaging clinics of North America.
[20] C. Kuhl. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. , 2007, Radiology.
[21] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[22] Peter L Choyke,et al. Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.
[23] C. Nimsky,et al. Proton Magnetic Resonance Spectroscopic Imaging in the Border Zone of Gliomas: Correlation of Metabolic and Histological Changes at Low Tumor Infiltration—Initial Results , 2007, Investigative radiology.
[24] A. Cilotti,et al. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion , 2007, European Radiology.
[25] Paul A. Bottomley,et al. Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI , 2007, Breast Cancer Research and Treatment.
[26] Frederik De Keyzer,et al. Extracranial applications of diffusion-weighted magnetic resonance imaging , 2007, European Radiology.
[27] Mauricio Castillo,et al. Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer. , 2006, The Lancet. Oncology.
[28] Elias R Melhem,et al. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.
[29] Sukru Mehmet Erturk,et al. High-B-value diffusion-weighted MRI in colorectal cancer. , 2006, AJR. American journal of roentgenology.
[30] Wei Huang,et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. , 2006, Radiology.
[31] J. Schramm,et al. Low-Grade Gliomas - Current Concepts , 2006, Zentralblatt fur Neurochirurgie.
[32] Susan M. Chang,et al. Diagnosis and treatment of recurrent high-grade astrocytoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] Christopher Nimsky,et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. , 2006, Radiology.
[34] L. Turnbull,et al. Diffusion Imaging of the Prostate at 3.0 Tesla , 2006, Investigative radiology.
[35] L. Turnbull,et al. Diffusion‐weighted imaging of normal and malignant prostate tissue at 3.0T , 2006, Journal of magnetic resonance imaging : JMRI.
[36] M. Lesniak,et al. Surgical management of high-grade gliomas , 2005, Expert review of neurotherapeutics.
[37] Hans H Schild,et al. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. , 2005, Radiology.
[38] Masahiko Watanabe,et al. Diffusion-Weighted Imaging of Malignant Breast Tumors: The Usefulness of Apparent Diffusion Coefficient (ADC) Value and ADC Map for the Detection of Malignant Breast Tumors and Evaluation of Cancer Extension , 2005, Journal of computer assisted tomography.
[39] K. Brandt,et al. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. , 2005, Radiology.
[40] Takeo Ishigaki,et al. Diffusion‐weighted images of the liver: Comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide , 2005, Journal of magnetic resonance imaging : JMRI.
[41] D. Yeung,et al. In vivo 1H MR spectroscopy of thyroid carcinoma. , 2005, European journal of radiology.
[42] Christopher Nimsky,et al. Proton Magnetic Resonance Spectroscopic Imaging Integrated into Image-guided Surgery: Correlation to Standard Magnetic Resonance Imaging and Tumor Cell Density , 2005, Neurosurgery.
[43] Takeo Ishigaki,et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate , 2005, Journal of magnetic resonance imaging : JMRI.
[44] M. Kattan,et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.
[45] P. Carroll,et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.
[46] D. Yee,et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T. , 2004, Radiology.
[47] J. Kurhanewicz,et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. , 2004, Radiology.
[48] C. Nimsky,et al. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas , 2004, NeuroImage.
[49] T. Brown,et al. Methodological standardization for a multi‐institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies , 2004, NMR in biomedicine.
[50] K. Hosseinzadeh,et al. Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue , 2004, Journal of magnetic resonance imaging : JMRI.
[51] Christopher Nimsky,et al. Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set. , 2004, Journal of neurosurgery.
[52] I. Cox,et al. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study , 2004, NMR in biomedicine.
[53] T. Brown,et al. Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. , 2004, Academic radiology.
[54] G. Shah,et al. Magnetic Resonance Spectroscopy of Head and Neck Neoplasms , 2004, Topics in magnetic resonance imaging : TMRI.
[55] I. Cox,et al. 1H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: In vivo–ex vivo profiles and effect of tumor load , 2004, Journal of magnetic resonance imaging : JMRI.
[56] D. Yeung,et al. In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. , 2004, AJNR. American journal of neuroradiology.
[57] A. Häkkinen,et al. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. , 2004, Radiology.
[58] I. Cox,et al. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration , 2004, NMR in biomedicine.
[59] Glyn Johnson,et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.
[60] Winnie C W Chu,et al. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. , 2003, AJR. American journal of roentgenology.
[61] Franklyn A Howe,et al. 1H MR spectroscopy of brain tumours and masses , 2003, NMR in biomedicine.
[62] Paul A Bottomley,et al. Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. , 2003, Radiology.
[63] Carles Arús,et al. Proton magnetic resonance spectroscopy (1H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization , 2003, European Radiology.
[64] V. L. Doyle,et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.
[65] Damien Galanaud,et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. , 2003, Journal of neurosurgery.
[66] Carles Arús,et al. Automated classification of short echo time in in vivo 1H brain tumor spectra: A multicenter study , 2003, Magnetic resonance in medicine.
[67] M. Kitajima,et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI , 2002, Neuroradiology.
[68] Roland G Henry,et al. Characterization of untreated gliomas by magnetic resonance spectroscopic imaging. , 2002, Neuroimaging clinics of North America.
[69] Carles Arús,et al. Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis. , 2002, Radiology.
[70] Ning-Yu An,et al. Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[71] L. Liberman,et al. Breast lesions detected on MR imaging: features and positive predictive value. , 2002, AJR. American journal of roentgenology.
[72] Mark Rijpkema,et al. Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels. , 2002, Academic radiology.
[73] L. Esserman,et al. Magnetic resonance imaging for primary breast cancer management: current role and new applications. , 2002, Endocrine-related cancer.
[74] Mauricio Castillo,et al. Clinical Applications of Proton MR Spectroscopy in Oncology , 2002, Technology in cancer research & treatment.
[75] V. Stieber. Low-grade gliomas , 2001, Current treatment options in oncology.
[76] T. Mikkelsen,et al. Correlation between Magnetic Resonance Spectroscopy Imaging and Image-guided Biopsies: Semiquantitative and Qualitative Histopathological Analyses of Patients with Untreated Glioma , 2001, Neurosurgery.
[77] Robert E. Lenkinski,et al. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy , 2001, Breast Cancer Research and Treatment.
[78] D. Yeung,et al. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results. , 2001, Radiology.
[79] J. Nelson,et al. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. , 2001, Cancer research.
[80] S. Dwivedi,et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer , 2001, British Journal of Cancer.
[81] G. Kemp,et al. Non-Invasive Methods for Studying Brain Energy Metabolism: What They Show and What It Means , 2000, Developmental Neuroscience.
[82] E A Sickles,et al. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. , 2000, AJR. American journal of roentgenology.
[83] T. Helbich,et al. Contrast-enhanced magnetic resonance imaging of the breast. , 2000, European journal of radiology.
[84] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[85] F. Podo. Tumour phospholipid metabolism , 1999, NMR in biomedicine.
[86] I. Gribbestad,et al. Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.
[87] T. Parrish,et al. Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. , 1999, Circulation.
[88] M. Castillo,et al. Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. , 1999, Topics in magnetic resonance imaging : TMRI.
[89] M. Castillo,et al. Proton MR spectroscopy of common brain tumors. , 1998, Neuroimaging clinics of North America.
[90] R. Lenkinski,et al. Human breast lesions: characterization with proton MR spectroscopy. , 1998, Radiology.
[91] Anna L. Brown,et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[92] Stephen Ashwal,et al. Proton Magnetic Resonance Spectroscopy: An Emerging Technology in Pediatric Neurology Research , 1998, Pediatric Research.
[93] J. H. Lee,et al. Localized in vivo 1H nuclear MR spectroscopy for evaluation of human uterine cervical carcinoma. , 1998, AJR. American journal of roentgenology.
[94] Susan M. Chang,et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. , 1997, Journal of neurosurgery.
[95] N. Lundbom,et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997, Journal of Neurosurgery.
[96] K. Muller,et al. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. , 1997, AJNR. American journal of neuroradiology.
[97] S B Reeder,et al. Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. , 1997, Circulation.
[98] P. Carroll,et al. Focal therapy for prostate cancer 1996: maximizing outcome. , 1997, Urology.
[99] A Heinig,et al. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. , 1997, European journal of radiology.
[100] R. Kim,et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.
[101] M. Castillo,et al. Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. , 1996, AJNR. American journal of neuroradiology.
[102] T R Brown,et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.
[103] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[104] B. Asselain,et al. Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. , 1995, European journal of cancer.
[105] T E Conturo,et al. Diffusion MRI: Precision, accuracy and flow effects , 1995, NMR in biomedicine.
[106] D. Ballon,et al. In vitro and in vivo 31P nuclear magnetic resonance measurements of metabolic changes post radiation. , 1995, Cancer research.
[107] J G Pipe,et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. , 1995, AJNR. American journal of neuroradiology.
[108] P. Viehweg,et al. Sensitivity of contrast-enhanced MR imaging of the breast. , 1994, Magnetic resonance imaging clinics of North America.
[109] H. Thaler,et al. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy. , 1994, Cancer research.
[110] R D Tien,et al. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. , 1994, AJR. American journal of roentgenology.
[111] C. Mountford,et al. Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. , 1993, Radiology.
[112] J. Frahm,et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.
[113] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[114] J Hennig,et al. Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.
[115] H. Degani,et al. Phosphate metabolites and steroid hormone receptors of benign and malignant breast tumors. A nuclear magnetic resonance study , 1991, Cancer.
[116] B. Rajagopalan,et al. Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. , 1991, British Journal of Cancer.
[117] B. Miller. A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.
[118] J A Frank,et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. , 1990, Radiology.
[119] P. V. van Zijl,et al. Proton magnetic resonance spectroscopy of small regions (1 mL) localized inside superficial human tumors. A clinical feasibility study , 1990, NMR in biomedicine.
[120] J. Frahm,et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.
[121] W. Kaiser,et al. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. , 1989, Radiology.
[122] S. Green,et al. Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.
[123] I. Nagy,et al. Correlation of malignancy with the intracellular Na+:K+ ratio in human thyroid tumors. , 1983, Cancer research.
[124] I. Cameron,et al. Intracellular concentration of sodium and other elements as related to mitogenesis and oncogenesis in vivo. , 1980, Cancer research.
[125] E. R. Andrew,et al. Nuclear Magnetic Resonance , 1955 .
[126] M. Vendrell. Enhancing Nonmass Lesions in the Breast: Evaluation with Proton (1H) MR Spectroscopy: Bartella L, Thakur SB, Morris EA, et al (Memorial Sloan-Kettering Cancer Ctr, New York, NY) Radiology 245:80-87, 2007§ , 2009 .
[127] H. Hricak,et al. Imaging of prostate cancer. , 2007, Radiologic clinics of North America.
[128] Thomas E Yankeelov,et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. , 2007, Magnetic resonance imaging.
[129] L. Liberman,et al. Imaging breast cancer. , 2007, Radiologic clinics of North America.
[130] P. Carroll,et al. Magnetic resonance imaging and spectroscopy of prostate cancer. , 2006, Reviews in urology.
[131] Elizabeth A. Morris,et al. Advances in breast imaging: Magnetic resonance imaging , 2006, Current oncology reports.
[132] Ewald Moser,et al. Proton magnetic resonance spectroscopic imaging in brain tumor diagnosis. , 2005, Neurosurgery clinics of North America.
[133] Masanori Ozaki,et al. ADC mapping of benign and malignant breast tumors. , 2005, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[134] Thomas Dierks,et al. Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. , 2003, Journal of neurosurgery.
[135] Edward Pan,et al. Glioblastoma Multiforme and Anaplastic Astrocytoma , 2003 .
[136] E. Adalsteinsson,et al. In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. , 2000, AJNR. American journal of neuroradiology.
[137] H. Hricak,et al. The prostate: MR imaging and spectroscopy. Present and future. , 2000, Radiologic clinics of North America.
[138] M. Castillo,et al. Clinical applications of proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.
[139] M Hoehn-Berlage,et al. Quantitative diffusion MR imaging of cerebral tumor and edema. , 1994, Acta neurochirurgica. Supplementum.
[140] M. Dewhirst,et al. MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. , 1994, Radiology.